Cardio Diagnostics Statistics
NASDAQ: CDIOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
1.96-0.04 (-2.00%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cardio Diagnostics by the numbers
Cardio Diagnostics has a market capitalization of $5.8 million based on 2.96M shares outstanding. With trailing EPS of $-2.91, Cardio Diagnostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.3% above its 50-day average and 9.4% below its 200-day average.
Average daily trading volume is 55.78K shares, or about $109,333 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CDIO valuation vs. peer median
| Metric | CDIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.80M | $7.79M | -26% |
| Avg. volume | 55.78K | 1.02M | -95% |
Peer median across 8 companies: TRIB, QCLS, VNRX, VRAX, BMRA, ICCC, IMDX, NTLA.
Valuation
- Market cap
- $5.80M
- EPS (TTM)
- $-2.91
- Shares outstanding
- 2.96M
Price and trading
- Previous close
- 2.00
- Open
- 2.00
- Day range
- 1.96 – 2.03
- 52-week range
- 0.97 – 7.91
- Beta
- —
- Volume
- 29.96K
- Average volume
- 55.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 5.80M
- Forward Pe
- -7.84
- Eps
- -2.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.91
- Week52 Low
- 0.97
- Avg Volume
- 55,782.00
- Shares Outstanding
- 2.96M
- Ma50
- 1.90
- Ma200
- 2.16
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -75.22%
- Pct From52w Low
- 102.06%